Stroke occurs across the lifespan with unique issues in the fetus, neonate, and child. The
past decade has seen substantial advances in paediatric stroke research and clinical care …

Stroke is a rare disease in childhood with an estimated incidence of 1-6/100.000. It has an
increasingly recognised impact on child mortality along with its outcomes and effects on …

Цель работы: анализ современных принципов лечения больных с ишемическим
инсультом (ИИ). Основные положения. ИИ—одна из основных причин …

BACKGROUND AND PURPOSE: Acute vertebrobasilar occlusion is an ominous disease
with few proved effective treatments. Experience with stent retrievers is scarce and limited to …

Objective: The results of Interventional Management of Stroke (IMS) III, Magnetic Resonance
and REcanalization of Stroke Clots Using Embolectomy (MR RESCUE), and SYNTHESIS …

Ischemic stroke is the most widespread cause of disability and a leading cause of death in
developed countries. To date, the most potent approved treatment for acute stroke is …

Background Attempts to clarify mechanisms of early brain injury in subarachnoid
hemorrhage (SAH) revealed a high-mobility group box 1 (HMGB1) protein involvement in …

Cerebral oximetry using near‐infrared spectroscopy (NIRS) allows for continuous monitoring
of cerebral perfusion and immediate treatment of hemodynamic perturbations. In …

Background Alberta Stroke Program Early CT Score (ASPECTS) represents the extent of
irreversibly damaged tissue; while CT angiography collateral score (CTA-CS) denotes the …

Abstract Plasminogen activator inhibitor-1 (PAI-1) is an endogenous inhibitor of tissue
plasminogen activator (tPA) that acts as a neuromodulator in various neurophysiological …